D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 75 Citations 17,007 373 World Ranking 14736 National Ranking 600

Overview

What is he best known for?

The fields of study he is best known for:

  • Cancer
  • Internal medicine
  • Radiation therapy

Michael Milosevic spends much of his time researching Radiation therapy, Internal medicine, Surgery, Hypoxia and Cancer. His studies deal with areas such as Magnetic resonance imaging, Prostate cancer and Cervix as well as Radiation therapy. His work on Internal medicine is being expanded to include thematically relevant topics such as Oncology.

The various areas that he examines in his Surgery study include Univariate analysis and Urology. His studies in Hypoxia integrate themes in fields like Pathology, Disease and Clinical significance. In general Cancer, his work in Metastasis is often linked to Clinical Practice linking many areas of study.

His most cited work include:

  • Oxygenation predicts radiation response and survival in patients with cervix cancer (557 citations)
  • Oxygenation predicts radiation response and survival in patients with cervix cancer (557 citations)
  • Expanding global access to radiotherapy (352 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of investigation include Radiation therapy, Internal medicine, Cervical cancer, Oncology and Cancer. His research integrates issues of Prostate cancer, Nuclear medicine and Chemotherapy in his study of Radiation therapy. Michael Milosevic has included themes like Dose fractionation and Magnetic resonance imaging in his Nuclear medicine study.

The study incorporates disciplines such as Gastroenterology and Pathology in addition to Internal medicine. Michael Milosevic has researched Cervical cancer in several fields, including External beam radiotherapy, Brachytherapy, Cisplatin, Lymph node and Dosimetry. A large part of his Cancer studies is devoted to Cervix.

He most often published in these fields:

  • Radiation therapy (68.02%)
  • Internal medicine (41.44%)
  • Cervical cancer (38.51%)

What were the highlights of his more recent work (between 2016-2021)?

  • Cervical cancer (38.51%)
  • Radiation therapy (68.02%)
  • Internal medicine (41.44%)

In recent papers he was focusing on the following fields of study:

Cervical cancer, Radiation therapy, Internal medicine, Brachytherapy and Cancer are his primary areas of study. His work deals with themes such as Hypoxia, Tumor hypoxia, Cisplatin, Radiology and Locally advanced, which intersect with Cervical cancer. Radiation therapy is a subfield of Surgery that Michael Milosevic studies.

His Internal medicine study integrates concerns from other disciplines, such as Gastroenterology and Oncology. His Brachytherapy research is multidisciplinary, incorporating perspectives in Magnetic resonance imaging, Mri guided, Medical physics and Nuclear medicine. His research in Cancer is mostly concerned with Cervix.

Between 2016 and 2021, his most popular works were:

  • Propensity score analysis of radical cystectomy versus bladder-sparing trimodal therapy in the setting of a multidisciplinary bladder cancer clinic (128 citations)
  • Vulnerabilities of radiomic signature development: The need for safeguards. (101 citations)
  • Radiation effects on the tumor microenvironment: Implications for nanomedicine delivery. (71 citations)

In his most recent research, the most cited papers focused on:

  • Cancer
  • Internal medicine
  • Radiation therapy

His scientific interests lie mostly in Radiation therapy, Internal medicine, Cervical cancer, Cancer and Oncology. His Radiation therapy study is concerned with Surgery in general. His Surgery research incorporates themes from Carcinoma in situ and Cystectomy.

His Cervical cancer research is multidisciplinary, incorporating elements of Cisplatin, Repeatability, Reproducibility, Stage and Cohort. The Cancer study combines topics in areas such as Hypoxia, Gastroenterology, Confidence interval, Physical therapy and Nanomedicine. His work focuses on many connections between Oncology and other disciplines, such as Chemoradiotherapy, that overlap with his field of interest in Primary tumor.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Oxygenation predicts radiation response and survival in patients with cervix cancer

Anthony W Fyles;Anthony W Fyles;Michael Milosevic;Michael Milosevic;Raimond Wong;Raimond Wong;Mary-Claire Kavanagh.
Radiotherapy and Oncology (1998)

869 Citations

Expanding global access to radiotherapy

Rifat Atun;David A Jaffray;David A Jaffray;David A Jaffray;Michael B Barton;Freddie Bray.
(2015)

708 Citations

Tumor Hypoxia Has Independent Predictor Impact Only in Patients With Node-Negative Cervix Cancer

A. Fyles;M. Milosevic;D. Hedley;M. Pintilie.
Journal of Clinical Oncology (2002)

538 Citations

Trends in the Utilization of Brachytherapy in Cervical Cancer in the United States

Kathy Han;Michael Milosevic;Anthony Fyles;Melania Pintilie.
International Journal of Radiation Oncology Biology Physics (2013)

456 Citations

Randomized study of brachytherapy in the initial management of patients with malignant astrocytoma

Normand J Laperriere;Phil M.K Leung;Stephen McKenzie;Michael Milosevic.
International Journal of Radiation Oncology Biology Physics (1997)

368 Citations

Gut Microbial Metabolism Drives Transformation of Msh2-Deficient Colon Epithelial Cells

Antoaneta Belcheva;Thergiory Irrazabal;Susan J. Robertson;Catherine Streutker.
Cell (2014)

348 Citations

Interstitial Fluid Pressure Predicts Survival in Patients with Cervix Cancer Independent of Clinical Prognostic Factors and Tumor Oxygen Measurements

Michael Milosevic;Anthony Fyles;David Hedley;Melania Pintilie.
Cancer Research (2001)

318 Citations

Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study

Emilie Lalonde;Emilie Lalonde;Adrian S Ishkanian;Jenna Sykes;Michael Fraser;Michael Fraser.
Lancet Oncology (2014)

317 Citations

Diffusion-weighted MRI in cervical cancer

Patrick Z. McVeigh;Aejaz M. Syed;Michael Milosevic;Anthony Fyles.
European Radiology (2008)

299 Citations

Reprogramming Metabolism with Metformin Improves Tumor Oxygenation and Radiotherapy Response

Vanessa E. Zannella;Alan Dal Pra;Alan Dal Pra;Hala Muaddi;Hala Muaddi;Trevor D. McKee.
Clinical Cancer Research (2013)

274 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Michael Milosevic

Robert G. Bristow

Robert G. Bristow

University of Manchester

Publications: 129

Paul C. Boutros

Paul C. Boutros

University of California, Los Angeles

Publications: 70

Richard P. Hill

Richard P. Hill

Princess Margaret Cancer Centre

Publications: 57

Padraig Warde

Padraig Warde

Princess Margaret Cancer Centre

Publications: 56

David A. Jaffray

David A. Jaffray

The University of Texas MD Anderson Cancer Center

Publications: 48

Peter Hoskin

Peter Hoskin

Northwood University

Publications: 45

Philippe Lambin

Philippe Lambin

Maastricht University

Publications: 43

Bradly G. Wouters

Bradly G. Wouters

Princess Margaret Cancer Centre

Publications: 40

Mark W. Dewhirst

Mark W. Dewhirst

Duke University

Publications: 39

Christine Haie-Meder

Christine Haie-Meder

Institut Gustave Roussy

Publications: 37

Catharine M L West

Catharine M L West

University of Manchester

Publications: 36

Richard Pötter

Richard Pötter

Medical University of Vienna

Publications: 32

Jens Overgaard

Jens Overgaard

Aarhus University Hospital

Publications: 31

David P. Dearnaley

David P. Dearnaley

Institute of Cancer Research

Publications: 30

Jürgen Debus

Jürgen Debus

University Hospital Heidelberg

Publications: 29

Charles Catton

Charles Catton

University of Toronto

Publications: 28

Trending Scientists

Pol Antràs

Pol Antràs

Harvard University

Boon-Teck Ooi

Boon-Teck Ooi

McGill University

Giuseppe Marco Tina

Giuseppe Marco Tina

University of Catania

Michael J. Tarlov

Michael J. Tarlov

National Institute of Standards and Technology

Michael F. Greaney

Michael F. Greaney

University of Manchester

C. Neal Stewart

C. Neal Stewart

University of Tennessee at Knoxville

Myron I. Cybulsky

Myron I. Cybulsky

University Health Network

Bostjan Kobe

Bostjan Kobe

University of Queensland

Jürgen Behrens

Jürgen Behrens

University of Erlangen-Nuremberg

Bozena Kaminska

Bozena Kaminska

Polish Academy of Sciences

Flemming Scheutz

Flemming Scheutz

Statens Serum Institut

Fayyaz S. Sutterwala

Fayyaz S. Sutterwala

Cedars-Sinai Medical Center

Dengsheng Lu

Dengsheng Lu

Fujian Normal University

Christopher Schatschneider

Christopher Schatschneider

Florida State University

Edward J. McGuire

Edward J. McGuire

University of Michigan–Ann Arbor

John Ross

John Ross

University of California, San Diego

Something went wrong. Please try again later.